Bulletin
Investor Alert

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 23, 2022, 7:58 p.m.

/zigman2/quotes/207821052/composite

$

44.96

Change

-2.36 -4.99%

Volume

Volume 14,629

Quotes are delayed by 20 min

/zigman2/quotes/207821052/composite

Previous close

$ 47.74

$ 47.32

Change

-0.42 -0.88%

Day low

Day high

$46.48

$49.84

Open

52 week low

52 week high

$38.85

$202.73

Open

Eliana Clark

Currently, Eliana Clark occupies the position of Senior Vice President-Technical Operations at Intellia Therapeutics, Inc.

In the past Dr. Clark was Vice President at Biogen, Inc. and Professor at Tufts University.

Dr. Clark received a doctorate and an undergraduate degree from National University of the Littoral.

Transactions

Date Shares Transaction Value
03/01/2022 10,527   Award at $0 per share. 0

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Chairman
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.